Smart rings that measure blood pressure are no longer science fiction. Several devices now claim to track your blood pressure continuously from your finger, without an inflatable cuff, without a trip to the clinic, and without interrupting your day.
But there is a meaningful gap between "claims to measure" and "is clinically validated to measure." If you are managing hypertension or monitoring your cardiovascular health, that gap matters a great deal. This article walks through what the research actually shows, which devices are furthest along, and what you should realistically expect from this technology right now.
Quick Summary
| Question | Short Answer |
|---|---|
| Can smart rings measure blood pressure? | Some can estimate BP trends; none have full FDA clearance for BP diagnosis as of 2026 |
| Is the technology clinically validated? | One ring (CART-I Plus) showed under 1 mmHg mean difference vs. a reference cuff in a peer-reviewed trial |
| Are they FDA-approved for BP? | No smart ring currently holds FDA clearance specifically for blood pressure measurement |
| Can they replace a cuff monitor? | No. Current guidance recommends cuff monitors for any reading used in diagnosis or treatment |
| Who benefits most? | People monitoring trends over time, especially those tracking nocturnal or activity-related BP changes |
The Honest State of Smart Ring Blood Pressure Technology
Smart rings that track blood pressure use optical sensors, called photoplethysmography (PPG) sensors, to estimate blood flow by shining light through your skin. Some newer devices add a second measurement called Pulse Transit Time (PTT), which calculates how fast a pulse wave travels through your arteries. Because faster pulse waves are associated with stiffer arteries and higher blood pressure, PTT gives the ring more data to work with when estimating your reading.
The technology itself is sound. The challenge is accuracy at the population level, under real-world conditions, across different skin tones, finger sizes, and movement patterns.
A 2024 peer-reviewed trial published in the Journal of Korean Medical Science was the first human study to put a ring-type cuffless blood pressure device through rigorous clinical testing. The device, the CART-I Plus ring developed by Sky Lab Inc., was worn by 89 participants while a traditional arm cuff provided reference readings simultaneously. The mean difference between the ring and the reference cuff was 0.16 mmHg for systolic blood pressure and -0.07 mmHg for diastolic blood pressure. More than 90% of readings fell within 10 mmHg of the reference.
To put that in context: a difference of less than 1 mmHg on average is genuinely impressive for a cuffless device. The Association for the Advancement of Medical Instrumentation (AAMI) standard for validated blood pressure monitors allows a mean difference of up to 5 mmHg. The CART-I Plus ring, under controlled clinical conditions, cleared that bar comfortably.
A follow-up 2024 study in the Korean Circulation Journal compared the same ring against 24-hour ambulatory blood pressure monitoring. It found that the ring could detect both white coat hypertension (where blood pressure reads high in clinical settings but is normal at home) and masked hypertension (normal in clinic, elevated at home). Both conditions are notoriously difficult to identify without continuous home monitoring.
These are real clinical results. But the study samples are small, the device is not widely available in the US market, and controlled clinical conditions do not always reflect what happens when you are cooking dinner or walking to your car.
How a Smart Ring Measures Blood Pressure Without a Cuff
Traditional blood pressure monitors work by inflating a cuff around your arm to temporarily stop blood flow, then slowly releasing pressure while a sensor listens for when flow returns. That gives you a direct pressure reading.
Smart rings do something entirely different, and it is worth understanding the distinction before you evaluate any device's accuracy claims.
PPG: Reading Blood Flow With Light
PPG sensors, the same technology used in most fitness wearables, shine green or infrared LED light onto your skin. Blood absorbs light differently depending on volume and flow speed. The ring's photodetector measures how much light bounces back, and the fluctuation pattern that results maps to your pulse.
From that pulse waveform, algorithms estimate blood pressure by analyzing the shape and timing of each beat. This is an inference, not a direct measurement.
PTT: Measuring the Speed of Your Pulse
Pulse Transit Time adds a layer of precision. PTT calculates the time it takes for a pulse wave to travel from one point in your cardiovascular system to another. Arteries under higher pressure tend to be stiffer, and stiffer arteries conduct pulse waves faster.
Bioimpedance: A Skin-Tone-Neutral Alternative
A 2023 study published in Nature npj Digital Medicine explored a ring-based bioimpedance sensor as an alternative to optical PPG. Unlike optical sensors, bioimpedance sends a low-level electrical signal through your finger tissue and reads how that signal changes based on arterial blood volume. One significant advantage: it is not affected by skin tone or pigmentation, which can interfere with PPG readings in some individuals.
Why the Finger Has an Advantage Over the Wrist
Finger arteries sit closer to the skin surface than wrist arteries, which gives PPG sensors a cleaner signal with less interference from surrounding tissue. That is one reason researchers have focused on ring-based BP monitoring rather than extending wrist-worn smartwatch technology to this use case.
What the FDA and AHA Actually Say
Understanding the regulatory picture is not a footnote. It is the frame through which you should read every blood pressure claim on any smart ring's product page.
As of 2026, no smart ring holds FDA clearance specifically for blood pressure measurement or hypertension management.
The American Heart Association addressed this directly in a December 2025 scientific statement: cuffless blood pressure devices, including smart rings, "show great promise" but are "not yet proven accurate enough to diagnose high blood pressure or guide treatment decisions." The AHA explicitly recommended that any reading from a ring or smartwatch being shared with a physician should be accompanied by a disclosure that it came from a cuffless device, and that a validated cuff monitor should be used for any reading relevant to diagnosis or medication management.
That guidance applies to every device currently on the market.
What FDA Clearance Does and Does Not Mean for Rings
Several smart rings carry FDA clearance for specific features, such as heart rate monitoring, blood oxygen saturation (SpO2) detection, or atrial fibrillation (AFib) screening. FDA clearance for one feature does not extend to others. A ring that is FDA-cleared for AFib detection is not automatically cleared for blood pressure monitoring.
Oura announced in October 2025 that it had received FDA approval to begin a study evaluating a blood pressure feature. That study is ongoing. Oura's ring does not currently offer a blood pressure reading to consumers.
The Circular Ring 2 is FDA-cleared for ECG measurement and AFib detection, making it the first smart ring to hold that specific clearance. It is developing a blood pressure feature using combined ECG and PPG sensors to estimate PTT, but that feature is not yet cleared or commercially available for BP monitoring purposes.
Smart Rings With Blood Pressure Features: An Honest Comparison
The market for smart rings that track blood pressure breaks down into three tiers: devices with peer-reviewed clinical evidence, devices with early-stage BP features under development, and budget devices making claims without published validation.
Tier 1: Clinically Studied
CART-I Plus (Sky Lab Inc.): The only ring with a peer-reviewed first-in-human clinical trial specifically for blood pressure, published in the Journal of Korean Medical Science. Not widely available in the US consumer market. Used as a research device.
Tier 2: BP Features in Active Development
Circul Ring (BodiMetrics): Markets continuous blood pressure monitoring using PPG sensors. Uses the palmar surface of the finger, which the company says reduces interference from skin pigmentation. The device's own product page notes the BP feature is "intended for research and innovation purposes only" and does not constitute medical advice.
Circular Ring 2: Combines ECG and PPG to estimate blood pressure via PTT. The company states this makes it the first smart ring to use this sensor combination for spot BP measurements. A software update enabling the feature was planned for late 2025. No independent peer-reviewed validation has been published for this device's BP readings.
Oura Ring 4: No consumer blood pressure feature currently available. FDA-approved study underway as of October 2025.
Tier 3: Budget Rings Claiming Blood Pressure Monitoring
Dozens of rings available on major retail platforms list blood pressure monitoring in their feature descriptions at price points from $20 to $80. Nearly all include a disclaimer in their own documentation that "readings are for reference only" and that the device "is not a professional medical device." None of these rings have published clinical validation for their blood pressure claims.
According to a 2024 meta-analysis in MDPI Applied Sciences reviewing smart ring health monitoring studies, clinical validation varies dramatically across consumer devices. The review found that most consumer smart rings have stronger evidence for sleep tracking than for blood pressure monitoring.
If blood pressure accuracy is your primary need, the difference between a clinically studied device and an unvalidated budget ring is not a marginal one.
Accuracy Limitations Worth Knowing Before You Buy
The CART-I Plus trial results are encouraging. But a mean difference of 0.16 mmHg was measured under controlled clinical conditions, with participants seated quietly, across a limited sample of 89 people. Real-world accuracy is harder to guarantee.
Several factors reliably affect optical BP readings:
Motion artifacts: Movement during measurement disrupts the PPG signal. Most rings require a period of stillness for a reading. Continuous passive monitoring during activity remains technically challenging.
Skin tone and optical interference: Darker skin tones can absorb more LED light, reducing the signal-to-noise ratio in PPG sensors. Harvard Health noted in its December 2024 review of smart rings that this remains an area where device performance varies and where ongoing research is needed. Bioimpedance-based rings avoid this limitation entirely.
Finger temperature: Cold fingers reduce peripheral blood flow. In cold environments, PPG readings can become less reliable because circulation to the extremities decreases.
Calibration requirements: Most smart rings that track blood pressure require an initial calibration using a traditional arm-cuff monitor to establish a personal baseline. Without that baseline, the ring's algorithm has nothing to anchor its estimates to. Some manufacturers recommend recalibrating every few weeks, or after any significant change in blood pressure medication or health status.
How to Calibrate Your Ring Correctly
If your ring requires calibration:
- Use a validated arm-cuff monitor. If you do not already have one, some programs provide free blood pressure monitors to eligible individuals, which is worth exploring before purchasing one separately.
- Sit quietly for five minutes before measuring.
- Take three readings with the cuff, one minute apart, and use the average.
- Complete the calibration process in your ring's app using that average.
- Repeat if your physician adjusts your medication or if you notice consistent discrepancies between your ring's readings and cuff measurements.
Who Benefits Most From a Blood Pressure Smart Ring
Smart rings are not the right tool for every person managing blood pressure. But for specific situations, continuous passive monitoring fills a real clinical gap.
People with white coat hypertension: If your blood pressure is consistently higher in medical settings than at home, 24-hour home monitoring can help your physician get a more accurate picture. The Korean Circulation Journal study found that a ring-type device could detect this pattern across continuous readings. Many people are surprised to learn what high blood pressure actually feels like day to day, which is part of why continuous monitoring adds value that periodic office visits alone cannot replicate.
People with nocturnal hypertension: Blood pressure normally dips during sleep. When it does not, the pattern is associated with increased cardiovascular risk. Traditional home monitors require you to wake up to take a reading. A ring can capture the overnight picture passively. Some people with persistently elevated overnight readings also find that high blood pressure contributes to daytime fatigue, and continuous tracking can help connect those symptoms to an overnight BP pattern.
People monitoring lifestyle changes: If you are tracking whether dietary changes, exercise, or stress reduction are affecting your blood pressure over time, trend data from a ring can be a useful supplement to periodic cuff readings. Hydration is one factor that is easy to overlook: dehydration can contribute to elevated blood pressure, and a ring tracking diurnal BP patterns can make that connection more visible.
People who need data for clinical conversations: Bringing weeks of trend data to a cardiology appointment gives your physician more context than a single office reading. If you are working toward better continuous heart health tracking, a smart ring can contribute meaningful data to that goal, provided you also maintain cuff-based readings for any clinical decision.
Who Should Be Cautious
Anyone adjusting blood pressure medication based on ring readings alone is working with insufficient data. Anyone diagnosed with arrhythmia may find that irregular heart rhythms affect the accuracy of PPG-based readings. A doctor can advise on individual cases and whether a specific ring is appropriate for your situation.
How to Use Smart Ring Data With Your Doctor
The AHA's December 2025 guidance was direct: if you are using a cuffless ring to monitor blood pressure, your physician needs to know that. Here is what that looks like in practice.
When sharing readings with your care team:
- Export your ring's trend data as a PDF or screenshot from the app before your appointment.
- Label it clearly as "cuffless ring estimate, not validated cuff measurement."
- Bring a parallel log of arm-cuff readings taken on the same days where possible.
- Do not present ring readings as equivalent to cuff readings for medication decisions.
When your ring flags a high reading: A ring showing elevated blood pressure for several days in a row warrants a conversation with your physician, not a self-adjustment of medication. Use it as a prompt to schedule a check-in and bring your trend data.
When to use a validated cuff monitor instead: Any reading that will be used to diagnose hypertension, adjust medication, or assess treatment response should come from a validated arm-cuff device. The AHA maintains a list of validated devices at validatebp.org.
If you are looking for a physician who can interpret your wearable data in context, finding a doctor near you who integrates remote monitoring into their practice can make that conversation much easier.
What Comes Next for Smart Ring Blood Pressure Technology
The trajectory here is genuinely promising. Sensor miniaturization, AI-driven algorithms trained on larger and more diverse datasets, and regulatory interest from the FDA are all accelerating development. Oura's ongoing FDA study, Circular's ECG-PPG sensor combination, and bioimpedance research from academic groups all point toward a future where ring-based BP readings are meaningfully more reliable.
But "promising" and "ready for clinical use" are not the same thing in 2026.
The researchers who published the first-in-human CART-I Plus trial concluded that the device "has the potential to provide accurate long-term BP monitoring in daily life." That potential is real. But potential and regulatory clearance are separated by exactly the kind of rigorous, diverse-population, real-world validation that takes time to produce.
The best position for a consumer right now is to treat a blood pressure smart ring as a trend-monitoring tool, not a diagnostic device. Use it alongside a validated cuff monitor, not instead of one, and keep your physician informed about the source of any data you share.
Frequently Asked Questions
Can any smart ring accurately measure blood pressure? One ring, the CART-I Plus, demonstrated under 1 mmHg mean difference from a reference cuff in a peer-reviewed clinical trial under controlled conditions. Consumer rings on the market have not all undergone the same level of independent validation. Accuracy under real-world conditions varies by device and has not been established for most consumer smart rings.
Are smart rings FDA-approved for blood pressure? No smart ring currently holds FDA clearance or approval specifically for blood pressure measurement. Some rings are FDA-cleared for other features, such as heart rate monitoring or AFib detection. Oura is conducting an FDA-approved study on a blood pressure feature, but no consumer BP feature from Oura is available yet.
What is the most accurate smart ring for blood pressure? The CART-I Plus ring has the strongest peer-reviewed evidence for blood pressure accuracy based on published clinical data as of 2026. It is primarily a research device and not widely available in the US consumer market. Among consumer devices, the Circul Ring and Circular Ring 2 are furthest along in BP development, but independent validation studies have not been published for either.
How does a smart ring measure blood pressure without a cuff? Smart rings use photoplethysmography (PPG), which estimates blood flow by measuring how light interacts with blood under your skin. Some rings also calculate Pulse Transit Time (PTT), which infers arterial stiffness from pulse wave speed. Both are indirect estimates of blood pressure, not direct measurements the way a cuff provides.
Can a smart ring replace a blood pressure monitor? Not currently. The American Heart Association's December 2025 scientific statement recommends that any blood pressure reading used for diagnosis or treatment decisions should come from a validated arm-cuff device. Smart rings can complement cuff monitoring by providing trend data over time, but they are not a substitute for clinical-grade measurement.
References
-
Kim J. et al. First-in-Human Study for Evaluating the Accuracy of Smart Ring Based Cuffless Blood Pressure Measurement. J Korean Med Sci. 2024. https://pubmed.ncbi.nlm.nih.gov/38225785/
-
Lee H. et al. CART-I Plus ring vs 24-hr ambulatory blood pressure monitoring. Korean Circ J. 2024. https://pubmed.ncbi.nlm.nih.gov/38196118/
-
Continuous cuffless blood pressure monitoring with a wearable ring bioimpedance device. Nature npj Digital Medicine. 2023. https://www.nature.com/articles/s41746-023-00796-w
-
Device of the Month: Smart Ring. Harvard Health. December 2024. https://www.health.harvard.edu/heart-health/device-of-the-month-smart-ring
-
The Use of Smart Rings in Health Monitoring: A Meta-Analysis. MDPI Applied Sciences. 2024. https://www.mdpi.com/2076-3417/14/23/10778
